These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7529239)

  • 1. Characterization of PCR-ribotyping for Burkholderia (Pseudomonas) cepacia.
    Dasen SE; LiPuma JJ; Kostman JR; Stull TL
    J Clin Microbiol; 1994 Oct; 32(10):2422-4. PubMed ID: 7529239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular epidemiology of Pseudomonas cepacia determined by polymerase chain reaction ribotyping.
    Kostman JR; Edlind TD; LiPuma JJ; Stull TL
    J Clin Microbiol; 1992 Aug; 30(8):2084-7. PubMed ID: 1380010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of Burkholderia cepacia from cystic fibrosis patients living in Wales by PCR ribotyping.
    Ryley HC; Millar-Jones L; Paull A; Weeks J
    J Med Microbiol; 1995 Dec; 43(6):436-41. PubMed ID: 7473677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PCR ribotyping and endonuclease subtyping in the epidemiology of Burkholderia cepacia infection.
    Shreve MR; Johnson SJ; Milla CE; Wielinski CL; Regelmann WE
    Am J Respir Crit Care Med; 1997 Mar; 155(3):984-9. PubMed ID: 9117036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing species of the Burkholderia cepacia complex and Burkholderia gladioli by automated ribotyping.
    Brisse S; Verduin CM; Milatovic D; Fluit A; Verhoef J; Laevens S; Vandamme P; Tümmler B; Verbrugh HA; van Belkum A
    J Clin Microbiol; 2000 May; 38(5):1876-84. PubMed ID: 10790116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of different PCR approaches for characterization of Burkholderia (Pseudomonas) cepacia isolates.
    Liu PY; Shi ZY; Lau YJ; Hu BS; Shyr JM; Tsai WS; Lin YH; Tseng CY
    J Clin Microbiol; 1995 Dec; 33(12):3304-7. PubMed ID: 8586722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods.
    van Pelt C; Verduin CM; Goessens WH; Vos MC; Tümmler B; Segonds C; Reubsaet F; Verbrugh H; van Belkum A
    J Clin Microbiol; 1999 Jul; 37(7):2158-64. PubMed ID: 10364579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arbitrarily primed PCR and sequencing of 16S rDNA for epidemiological typing and species identification of Burkholderia cepacia isolates from Swedish patients with cystic fibrosis reveal genetic heterogeneity.
    Karpati F; Giedraitis V; Thore M; Lindman R; Monstein HJ; Hjelte L; Jonasson J
    APMIS; 2001 May; 109(5):389-400. PubMed ID: 11478687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex.
    Henry DA; Mahenthiralingam E; Vandamme P; Coenye T; Speert DP
    J Clin Microbiol; 2001 Mar; 39(3):1073-8. PubMed ID: 11230429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burkholderia cepacia complex: distribution of genomovars among isolates from the maize rhizosphere in Italy.
    Fiore A; Laevens S; Bevivino A; Dalmastri C; Tabacchioni S; Vandamme P; Chiarini L
    Environ Microbiol; 2001 Feb; 3(2):137-43. PubMed ID: 11321544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center.
    Petrucca A; Cipriani P; Valenti P; Santapaola D; Cimmino C; Scoarughi GL; Santino I; Stefani S; Sessa R; Nicoletti M
    Res Microbiol; 2003 Sep; 154(7):491-8. PubMed ID: 14499935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis.
    Steinbach S; Sun L; Jiang RZ; Flume P; Gilligan P; Egan TM; Goldstein R
    N Engl J Med; 1994 Oct; 331(15):981-7. PubMed ID: 7521938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates.
    Segonds C; Heulin T; Marty N; Chabanon G
    J Clin Microbiol; 1999 Jul; 37(7):2201-8. PubMed ID: 10364586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients.
    LiPuma JJ; Dulaney BJ; McMenamin JD; Whitby PW; Stull TL; Coenye T; Vandamme P
    J Clin Microbiol; 1999 Oct; 37(10):3167-70. PubMed ID: 10488171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III.
    Mahenthiralingam E; Bischof J; Byrne SK; Radomski C; Davies JE; Av-Gay Y; Vandamme P
    J Clin Microbiol; 2000 Sep; 38(9):3165-73. PubMed ID: 10970351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of restriction fragment length polymorphism analysis of 16S rDNA as a tool for genomovar characterisation within the Burkholderia cepacia complex.
    Vermis K; Vandekerckhove C; Nelis HJ; Vandamme PA
    FEMS Microbiol Lett; 2002 Aug; 214(1):1-5. PubMed ID: 12204364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients.
    McDowell A; Mahenthiralingam E; Moore JE; Dunbar KE; Webb AK; Dodd ME; Martin SL; Millar BC; Scott CJ; Crowe M; Elborn JS
    J Clin Microbiol; 2001 Dec; 39(12):4247-55. PubMed ID: 11724828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misidentification of a genomovar of Burkholderia cepacia by recA restriction fragment length polymorphism.
    Moore JE; Millar BC; Xu J; Crowe M; Redmond AO; Elborn JS
    J Clin Pathol; 2002 Apr; 55(4):309-11. PubMed ID: 11919219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology of cystic fibrosis-linked Burkholderia cepacia complex isolates from three national referral centres in Ireland.
    Crowley D; Daly M; Lucey B; Shine P; Collins JJ; Cryan B; Moore JE; Murphy P; Buckley G; Fanning S
    J Appl Microbiol; 2002; 92(5):992-1004. PubMed ID: 11972706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Source of Pseudomonas cepacia: ribotyping of isolates from patients and from the environment.
    Fisher MC; LiPuma JJ; Dasen SE; Caputo GC; Mortensen JE; McGowan KL; Stull TL
    J Pediatr; 1993 Nov; 123(5):745-7. PubMed ID: 7693902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.